31868214

Summary
Title
The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling.
Authors
  • Detarya M
  • Sawanyawisuth K
  • Aphivatanasiri C
  • Chuangchaiya S
  • Saranaruk P
  • Sukprasert L
  • Silsirivanit A
  • Araki N
  • Wongkham S
  • Wongkham C
Source
Glycobiology
Publication Date
2020 Apr 20
PubMed ID
31868214

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024